S
COGT icon

SignatureFD’s Cogent Biosciences COGT Stock Holding History

SignatureFD’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.54K Buy
118
+17
+17% +$628 ﹤0.01% 2810
2025
Q4 		$3.59K Hold
101
– – ﹤0.01% 2809
2025
Q3 		$1.45K Hold
101
– – ﹤0.01% 3018
2025
Q2 		$725 Sell
101
-110
-52% -$610 ﹤0.01% 3063
2025
Q1 		$1.26K Buy
211
+91
+76% +$713 ﹤0.01% 2992
2024
Q4 		$936 Hold
120
– – ﹤0.01% 3045
2024
Q3 		$1.3K Hold
120
– – ﹤0.01% 2945
2024
Q2 		$1.01K Hold
120
– – ﹤0.01% 2900
2024
Q1 		$806 Buy
120
+44
+58% +$272 ﹤0.01% 2974
2023
Q4 		$447 Buy
+76
New +$582 ﹤0.01% 2987
2023
Q1 		– Sell
-65
Closed -$751 – 3297
2022
Q4 		$751 Sell
65
-15
-19% -$186 ﹤0.01% 3028
2022
Q3 		$1K Buy
+80
New +$1.1K ﹤0.01% 2930

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

SignatureFD's COGT Position: Q1 2026 in Review

SignatureFD increased its Cogent Biosciences (COGT) stake by 17% in Q1 2026, buying an estimated $628 and bringing the position to 118 shares worth $4.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2810.

SignatureFD first reported a position in COGT in Q3 2022 and has held it in 12 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • SignatureFD held 118 shares of Cogent Biosciences worth $4.54K as of Q1 2026.
  • SignatureFD bought 17 Cogent Biosciences shares in Q1 2026, an estimated $628.
  • Cogent Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2810 holding.
  • SignatureFD first reported a position in Cogent Biosciences in Q3 2022 and has held it in 12 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.